4th Quarter - Report

ALSTON & BIRD LLP for TRAVERE THERAPEUTICS

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

H.R.1414, Camerons Law, to restore the amount of the Orphan Drug Tax Credit. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.

LobbyistCovered position, as disclosed
MARK RAYDER —
ROBERT SIGGINS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1414 (119th)

Medicare/Medicaid MMM

H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs, Medicare and Medicaid.

LobbyistCovered position, as disclosed
JAMES PATRICK PALUSKIEWICZ —
MARK RAYDER —
ROBERT SIGGINS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1518 (119th)

Pharmacy PHA

Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs. Most-Favored Nation and International Reference Pricing proposals.

LobbyistCovered position, as disclosed
MARK RAYDER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 946 (119th)

Health Issues HCR

Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.

LobbyistCovered position, as disclosed
JAMES PATRICK PALUSKIEWICZ —
MARK RAYDER —
ROBERT SIGGINS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 946 (119th), H.R. 1518 (119th)

Medical/Disease Research/Clinical Labs MED

Legislation regarding clinical research for rare diseases and orphan drug development, and the Accelerated Approval pathway. H.R.1262/S.932, Give Kids a Chance Act to renew PRV program. Related provisions in Pub. L. No. 119-21, One Big Beautiful Bill Act. The Newborn Screening Reauthorization Act.

LobbyistCovered position, as disclosed
JAMES PATRICK PALUSKIEWICZ —
MARK RAYDER —
ROBERT SIGGINS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1262 (119th), S. 932 (119th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.